Antiepileptic drug combinations not involving valproate and the risk of fetal malformations

Grants

Funding Acknowledgements

We acknowledge the help provided by professional and lay colleagues who referred patients to the Australian Pregnancy Register, and wish to thank the Scientific Advisory Board and the Ethical Research Committees of St. Vincent's Hospital, Monash Medical Centre, the Royal Melbourne Hospital, and other institutions for their continuing ethics oversight of the Register. The Register is grateful for support from the Epilepsy Society of Australia, The Royal Melbourne Hospital Neuroscience Foundation, Epilepsy Action, and financial assistance from the National Health and Medical Research Council and the pharmaceutical companies Sanofi-Aventis, Genzyme, UCB Pharma, Janssen-Cilag, Novartis, Sci-Gen, and Eisai.